Indomethacin-induced activation of the death receptor-mediated apoptosis pathway circumvents acquired doxorubicin resistance in SCLC cells

Small-cell lung cancers (SCLCs) initially respond to chemotherapy but are often resistant at recurrence. A potentially new method to overcome resistance is to combine classical chemotherapeutic drugs with apoptosis induction via tumour necrosis factor (TNF) death receptor family members such as Fas....

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: de Groot, D J A, Timmer, T, Spierings, D C J, Le, T K P, de Jong, S, de Vries, E G E
Materialtyp: Artigo
Språk:Inglês
Publicerad: Nature Publishing Group 2005
Ämnen:
Translational Therapeutics
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361992/
https://ncbi.nlm.nih.gov/pubmed/15812552
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602516
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk